Metaphore Pharmaceuticals, Inc. Raises $40.2 Million in Series D Financing
Funding to Support Promising Pipeline of Drug Candidates for Pain and Inflammation
25-Aug-2004 -
Metaphore Pharmaceuticals, Inc., an
emerging pharmaceutical company focused on the development of drugs for the
treatment of pain, autoimmune disorders and inflammation, announced that
it completed a $40.2 million Series D private equity financing in August 2004. Participants include existing ...
cancer pain
clinical trials
drug abuse
+2